What is ABT's current stock price?

As of now, ABT is trading at $124.99, with a daily change of -1.57%.

What are ABT stock strengths?

ABT strengths include Earnings are forecast to grow, .

What are the risks associated with ABT stock?

ABT Key risk is its Low Risk Level, .

What is ABT next earnings date?

ABT next earnings report is scheduled for Apr 15, 2025.

What is ABT's current stock rating?

ABT's current stock rating is Buy.

Should I buy ABT stock right now?

Based on the current rating of Buy, it is advisable to consider Buy as your next step with ABT stock.

Is ABT a Strong Buy right now?

ABT's current stock rating is Buy, which indicates whether it is a Strong Buy, Buy, Hold, Sell, or Strong Sell.

What does a 'Strong Buy' rating mean for ABT?

A 'Strong Buy' rating for ABT indicates that analysts are highly confident in the stock's potential for future growth.

What does a 'Strong Sell' rating mean for ABT?

A 'Strong Sell' rating for ABT suggests that analysts anticipate the stock will decline significantly and may not be a good investment.

What factors influence ABT's stock rating?

ABT's stock rating is influenced by factors such as market trends, earnings reports, risk factors, and overall sentiment from analysts.

Abbott Laboratories (ABT) Stock Analysis and Insights

LOGIN

Market Overview Trending Stocks Stock Screener Trade Ideas

Top Rated Most Active Strong Potential Positive Momentum Earnings Calendar

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist

ABT

Abbott Laboratories

$124.99

-$2.00 | -1.57%

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

Open

$ 126.00

MKT CAP

$ 216.27B

High

$ 126.82

VOL

$ 4.42M

Low

$ 122.02

AVG VOL

$ 7.65M

Chart

140.22

113.91

118.77

105.9

1year

6month

3month

1month

ABT Latest Headlines +

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Fri Apr 4, 2025

Potential

Reasons to Add ABT Stock to Your Portfolio Right Now. Investors feel optimistic about Abbotts robust strength in the EPD Diabetes and Nutrition businesses. However unfavorable forex impacts are concerning.

Fri Apr 4, 2025

Potential

Heres What to Expect From Abbott Laboratories Next Earnings Report. Abbott Laboratories is expected to announce its first-quarter results this month and analysts predict a single-digit growth in the companys bottom-line figure.

Fri Apr 4, 2025

Potential

Global Expansion in EPD and Innovations Support Abbott Stock. Abbotts Diabetes Care business continues to benefit from the growing sales of its flagship sensor-based continuous glucose monitoring system FreeStyle Libre.

Thu Apr 3, 2025

Activity

Potential

Gray Line Tennessee Launches airLINE Shuttle Service with Dedicated Lanes at BNA. Gray Line Tennessee is proud to announce the launch of its new airport shuttle service providing convenient and reliable transportation between Nashville International Airport (BNA) downtown Nashville and Cool Springs/Franklin TN.Nashville TN April 02 2025 --()-- Gray Line Tennessee is proud to announce the launch of its new airport shuttle service providing convenient and reliable transportation between Nashville

Wed Apr 2, 2025

Activity

Potential

ABT Factor-Based Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Wed Apr 2, 2025

Potential

ABT Stock to Gain From Early CE Mark Approval of Volt PFA System. Abbott achieves early CE Mark approval for the Volt PFA system.

Tue Apr 1, 2025

Activity

ABT Stock Gains Following the Positive TRILUMINATE Trial Results. Abbott presents positive TRILUMINATE Pivotal trial data which demonstrates TriClip systems safety and effectiveness at the ACC.25.

Tue Apr 1, 2025

Activity

Momentum

CVKD: Preparing for Phase 3 Trial of Tecarfarin. By Business UpdateGearing Up for Phase 3 Trial of TecarfarinCadrenal Therapeutics Inc. (NASDAQ:CVKD) is a biopharmaceutical company developing tecarfarin a late-stage novel oral and reversible anticoagulant intended to prevent heart attacks stroke and death due to blood clots in patients suffering from rare cardiovascular conditions requiring chronic anticoagulation. These conditions include patients with left ventricular assist devices (LVADs) pa

Mon Mar 31, 2025

Activity

Potential

Why Abbott Laboratories Stock Leaped by Almost 4% on Thursday. Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week thanks to news from Europe. Investors greeted this positively rewarding the company with a share price gain on the day that approached 4%. This was more than good enough to to

Thu Mar 27, 2025

Momentum

Explore our ABT Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ABT Stock Strategies
Effective Risk Management

FIND US ON

Receive our ABT Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

Ideas

Earnings

Overview

Analysis

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

ABT

Abbott Laboratories

$124.99

-$2.00 | -1.57%

Chart

140.22

113.91

118.77

105.9

1year

6month

3month

1month

Discover ABT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABT. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ABT Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ABT Stock trends

ABT Stock performance

ABT Stock analysis

ABT investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

ABT Stock Analysis for the Last 90 Days

ABT Risk Level

ABT Analysts Opinion

ABT Street Consensus

ABT Performance Sentiment

Technical Price Levels

ABT Financial Health

ABT Fair Price vs Current Price

Explore our ABT Stock insights

Receive our ABT Daily Alerts

ABT Stock Analysis for the Last 90 Days

ABT Street Consensus

Technical Price Levels

ABT Fair Price vs Current Price

Discover ABT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ABT. We're here to help you make informed investment decisions today.

Receive our ABT Daily Alerts